Machine-Learning-Based Radiomics MRI Model for Survival Prediction of Recurrent Glioblastomas Treated with Bevacizumab

Anti-angiogenic therapy with bevacizumab is a widely used therapeutic option for recurrent glioblastoma (GBM). Nevertheless, the therapeutic response remains highly heterogeneous among GBM patients with discordant outcomes. Recent data have shown that radiomics, an advanced recent imaging analysis m...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Diagnostics (Basel)
Main Authors: Ammari, Samy, Sallé de Chou, Raoul, Assi, Tarek, Touat, Mehdi, Chouzenoux, Emilie, Quillent, Arnaud, Limkin, Elaine, Dercle, Laurent, Hadchiti, Joya, Elhaik, Mickael, Moalla, Salma, Khettab, Mohamed, Balleyguier, Corinne, Lassau, Nathalie, Dumont, Sarah, Smolenschi, Cristina
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8305059/
https://ncbi.nlm.nih.gov/pubmed/34359346
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/diagnostics11071263
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados